1Sime R, I.ecube A, Genesc& J, et al. Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection[J]. Diabetes Care, 2006,29 ( 11 ):2462-2466.
2Kawaguchi T, Yoshida T, Harada M, et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through upregulation of suppressor of cytokine signaling 3[J] Am J Pathol, 2004,165(5) : 1499-1508.
3Tosone G, Borgia G, Gentile 1, et al. A case of pegylated interferon alpha related diabetic ketoacidosis~ can this complication be avoided [J]. Acta Diabetol, 2007,44 : 167-169.
4Imazeki F, Yokosuka O, Fukai K,et al. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitisC: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients [J]. Liver Int, 2008,28 (3) : 355-362.
2[2]Fattovich G,Giustina G,Favarato S,Ruol A.A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon.J Hepatol 1996; 24:38-47
3[3]Deutsch M,Dourakis S,Manesis EK,Gioustozi A,Hess G,Horsch A,Hadziyannis S.Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy.Hepatology 1997; 26:206-210
4[4]Mandac JC,Chaudhry S,Sherman KE,Tomer Y.The clinical and physiological spectrum of interferon-alpha induced thyroiditis:toward a new classification.Hepatology 2006; 43:661-672
5[5]Fabris P,Floreani A,Tositti G,Vergani D,De Lalla F,Betterle C.Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy.Aliment Pharmacol Ther 2003; 18:549-558
6[6]Maede Y,Morishita K,Iwamura K,Takayama Y,Tsukada Y,Kishino M,Shimizu T,Matsushima S,Komatsu T,Kasagi Y.Chronic hepatitis C with early complication of Grave's disease during the treatment of pegylated interferon alpha-2a.Nippon Naika Gakkai Zasshi 2005; 94:2600-2602
8[8]Koivisto VA,Pelkonen R,Cantell K.Effect of interferon on glucose tolerance and insulin sensitivity.Diabetes 1989; 38:641-647
9[9]Ishigami Y,Kanda T,Wada M,Shimizu Y.Glucose intolerance during interferon therapy in patients with chronic hepatitis type C.Nippon Rinsho 1994; 52:1901-1904
10[10]Imano E,Kanda T,Ishigami Y,Kubota M,Ikeda M,Matsuhisa M,Kawamori R,Yamasaki Y.Interferon induces insulin resistance in patients with chronic active hepatitis C.J Hepatol 1998; 28:189-193
